Special supplement for patients with cancer at risk of malnutrition
Part of Digestive system clinical trials.
This trial tests a special liquid supplement for patients with head, neck, lung, rectal, or esophageal cancer who are having radiation and are malnourished or at risk. The supplement is designed to be easier to digest if you have stomach or gut issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have head, neck, lung, rectal, or esophageal cancer and are starting or already on radiation therapy
- You are malnourished or at risk of malnutrition
- You have trouble digesting regular liquid supplements and need a special easy-to-digest type
- You can answer questions about your health and agree to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special nutrition drink, Fortimel, for people with colorectal, stomach, or lung cancer who are getting chemo, radiation, or immunotherapy. It aims to see if this extra nutrition can help patients who are at risk for malnutrition.
This trial tests whether a special medical nutrition drink can help people with advanced gastrointestinal cancer (stomach, colon, liver, pancreas, or esophagus) tolerate their first chemotherapy or immunotherapy better and stay healthier during treatment. You'll drink the nutrition supplement alongside your regular cancer treatment and have blood tests to see how it affects your body's response.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
This study tests whether a special medical nutrition (a drink/food meant for people who need medical nutrition) given around the time of surgery helps patients with gastrointestinal cancer recover better. It aims to see if this nutrition approach is safe and beneficial when cancer is being removed.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This trial studies whether a nutritional supplement helps people with head and neck squamous cell cancer when they are receiving radiation (with or without chemotherapy). You must be able to eat by mouth and have specific cancer types and recent CT imaging.
Hear when a new Oncological Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.